Neuren Pharmaceuticals Ltd

NEU

Company Profile

  • Business description

    Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.

  • Contact

    697 Burke Road
    Suite 201
    Camberwell
    MelbourneVIC3124
    AUS

    T: +61 390920480

    https://www.neurenpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    19

Stocks News & Analysis

stocks

Why I dislike dividend stocks

If you need income then buying dividend stocks makes perfect sense. But if you don’t then it makes little sense because it’s likely to limit building real wealth. Here’s what you should do instead.
stocks

Chart of the Week: Ramsay Health Care margins to rebound

Charts from our latest stock pitch for Ramsay Health Care show a clear path to improved profitability.
stocks

BlackRock earnings: Market gains and inflows drive AUM and revenue to record highs

We plan to raise our fair value estimate of BlackRock stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,375.9019.700.21%
CAC 408,188.59111.591.38%
DAX 4024,272.1990.820.38%
Dow JONES (US)46,165.1288.19-0.19%
FTSE 1009,436.0911.340.12%
HKSE25,888.5122.09-0.09%
NASDAQ22,661.528.56-0.04%
Nikkei 22548,277.74605.071.27%
NZX 50 Index13,389.1081.700.61%
S&P 5006,658.2912.77-0.19%
S&P/ASX 2009,068.4018.200.20%
SSE Composite Index3,916.234.020.10%

Market Movers